McDermott Will and Emery has issued a timely 18 page update on "Medicare Reimbursement of Telehealth" after the pandemic - after the public health emergency (PHE).
Access the new report with email registration here. Most of the report is in a three-column tabular format, specifying a topic (such as direct supervision rules, or audio-only visit rules), the current state under PHE, and potential changes after the PHE. Several dozen policy topics like these are summarized.
For those primarily interested in lab industry issues, note that telehealth potentially makes large alterations in the channels and pathways for both routine and specialized lab tests. E;g. a current article in JAMA by Scott Gottlieb notes,, "Home diagnostic tests will be increasingly coupled with telemedicine visits...This ability to connect at-home diagnostic tests with telemedicine and rapid turnaround of definitive laboratory testing will change infectious disease management."